GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) – Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government’s industrial strategy plans after Brexit.

Leave a Reply

Your email address will not be published. Required fields are marked *